GlaxoSmithKline News and Research

RSS

Brits gear up for pandemic while FDA warns about flu jabs side-effects

The British government says it plans to double its stockpile of antiviral drugs such as Tamiflu to cope with the possibility of a flu pandemic.

26 Nov 2007

GlaxoSmithKline to acquire Reliant Pharmaceuticals

GlaxoSmithKline and Reliant Pharmaceuticals Inc. have announced that they had reached an agreement under which Reliant will be acquired by GSK for $1.65 billion (800 million pounds Sterling) in cash.

21 Nov 2007

Early warning for anti-smoking drug Chantix

The drug watchdog in the United States, the Food and Drug Administration (FDA), has expressed concerns regarding the anti-smoking drug Chantix.

21 Nov 2007

Funds to boost UK methods research

A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.

19 Nov 2007

Rev-erb protein helps maintain the body's correct metabolism

It's well known that the body's energy levels cycle on a 24-hour, or circadian, schedule, and that this metabolic process is fueled by oxygen.

19 Nov 2007

Top selling diabetes drug to carry back box warning

The government watchdog body in the U.S., The Food and Drug Administration (FDA), has placed a "black box" warning on the popular drug Avandia.

15 Nov 2007

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.

15 Nov 2007

FDA adds warning for heart attacks to type 2 diabetes drug Avandia

The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks.

14 Nov 2007

Fabre Kramer Pharmaceuticals receives FDA decision on Gepirone ER for major depressive disorder

Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.

5 Nov 2007

Potent inhibitor of Kinesin CENP-E demonstrates tumor cell inhibition

A first-in-class, targeted investigational therapy specifically designed to inhibit a single protein that functions only during cell division shows potent activity in a broad range of cancer cell lines, say researchers from GlaxoSmithKline.

24 Oct 2007

Mylan settles Paroxetine Hydrochloride patent license with GlaxoSmithKline

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GSK's Paxil CR.

24 Oct 2007

Experimental cancer pharmaceuticals under trial

A potent and selective inhibitor of the mitotic kinesin CENP-E (GSK923295A) demonstrates a novel mechanism of inhibiting tumor cell proliferation and shows activity against a broad panel of human tumor cell lines in vitro: Abstract A 111.

24 Oct 2007

In the event of a bird flu pandemic more vaccine will be ready

The World Health Organization (WHO) has revised it's estimate of how much bird flu vaccine could be available were a pandemic scenario to unfold.

24 Oct 2007

Hispanics and African Americans are less likely to use commercial weight loss programs

A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss.

22 Oct 2007

Effective vaccine against malaria a very real possibility

The preliminary results of a malaria vaccine trial in African infants show that the vaccine gave a high level of protection and was also safe.

19 Oct 2007

When it comes to treatment for heart attacks white men get a better deal

Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.

4 Oct 2007

GlaxoSmithKline to pursue novel antibacterial research program for DOD

GlaxoSmithKline has announced that it has signed an agreement with the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DOD), to identify and develop a new class of antibacterials targeting both Gram negative biothreats and conventional Gram negative hospital pathogens.

18 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

GSK supports emphasis on asthma control in treatment guidelines

New asthma treatment guidelines issued today urge healthcare professionals to first assess the severity of a patient's asthma to determine and administer initial treatment and then obtain regular assessments of the patient's level of asthma control.

29 Aug 2007

Effects of obesity on egg and infertility discovered

A researcher at the University of Adelaide, Australia, has discovered scientific evidence that obesity is a key factor in infertility – because of how it affects women's eggs.

24 Aug 2007